Naringenin, Neohesperidin DC, and Phloretin Market Size 2031
Naringenin, Neohesperidin DC, and Phloretin Market Size 2031
Segments - Naringenin, Neohesperidin DC, and Phloretin Market by Type (Naringenin, Neohesperidin DC, and Phloretin), End-user Industry (Food & Feed Additives, Pharmaceutical, Healthcare, Cosmetics, Personal Care, Chemicals, and Others), and Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :MC-4886
| 4.9 Rating
| 69 Reviews
| 222 Pages
| Format :
Report Description
Naringenin, Neohesperidin DC, and Phloretin Market Outlook
The global Naringenin, Neohesperidin DC, and Phloretin Market size was USD 154 Mn in 2022 and is projected to reach USD 230.9 Mn by 2031, expanding at a CAGR of 4.6 % during the forecast period 2023-2031. The market growth is attributed to the increasing use of Naringenin and Neohesperidin DC as sweeteners in dairy products, ice creams, and desserts and in the pharmaceutical industry owing to the health benefits of these flavonoids.
Flavonoids are a group of natural substances with various phytochemical compounds present in plants, vegetables, fruits, and leaves with potential medicinal chemistry applications. They are a group of plant metabolites that provides health benefits through cells such as Neohesperidin DC, naringenin, and phloretin are also used for pharmaceutical applications.
Flavonoids are considered an indispensable component in various applications owing to its anti-inflammatory, oxidative, anti-mutagenic, and anti-carcinogenic properties. Growing demand for flavonoids has significantly propelled the pharmaceutical industry.
Research institutes have invested in clinical trials, and research activities for flavonoids, which increases the utilization of flavonoids in the treatment of chronic conditions, which is expected to drive the market. Phloretin is used in dermatological treatments such as melasma, acne, melanoma, and photoaging. It is a powerful antioxidant that helps in neutralizing the environmental-free radical damage that can show premature signs of aging.
Naringenin, Neohesperidin DC, and Phloretin Market Dynamics
Drivers
Flavonoids are phytochemical compound present in plants and vegetables. It finds several applications in medicinal chemistry. The biological benefits of flavonoids increase their utilization for treating several diseases, owing to their properties such as anticancer, anti-inflammatory, anti-viral, neuroprotective, and cardio-protective. These biological benefits and growing applications of flavonoids have proved their effectiveness in the treatment of several diseases.
Moreover, increasing the effectiveness of flavonoids in the treatment of diseases increases the usage of naringenin. It is a phytochemical flavonoid, which offers health benefits in the treatment of cancer and offers anti-inflammatory and antioxidant properties. Naringenin flavonoid offers several advantages in the nano-scaled drug delivery system, which is used to transport the drug to the diseased or targeted organ in the body of patients.
The advantages of the naringenin nanoscale drug delivery system include improvement in the safety profile and biocompatibility enhancing drug permeability in the drug delivery system and adding precision in the treatment of several chronic disorders. The growing application and effectiveness of flavonoids in treating diseases are anticipated to boost the naringenin segment.
The dietary bioactive compounds or polyphenolic compounds offer protection against chronic diseases or reduce their severity. The working population across the globe prefers the consumption of citrus fruits and vegetables containing plant-based dietary nutrients, which reduces the need for the treatment of chronic diseases.
Plant-based dietary nutrients include polyphenolic compounds such as flavonoids, which offer health benefits for the treatment of obesity, hypertension, and cardiovascular diseases. A citrus plant is a good source of plant-based nutrients, which includes flavonoids such as naringenin and neohesperidin. The consumption of citrus fruits, with plant-based dietary nutrients, is beneficial for the treatment of chronic diseases such as metabolic syndrome.
The presence of flavonoids such as naringenin and neohesperidin in citrus fruits and other food products increases the demand for the treatment of chronic diseases. The flavonoids present in food products, offer accuracy in the treatment and help in delaying the progression of cancer diseases. The rising application of flavonoids in the food & beverage sectors drives the naringenin segment.
Restraints
Neohesperidin DC is widely used as an artificial sweetener and the excessive intake of artificial sweeteners is associated with an increased risk of cardiovascular diseases which can hamper the global market. Artificial sweeteners are more particularly associated with cerebrovascular disease risk which includes major risk for strokes such as blood clots and coronary diseases which can hinder the global market.
Opportunities
Consumers prefer sugar-free drinks and ready-to-eat/drink foods and beverages to reduce and prevent obesity among patients. Rising cases of diabetes and obesity are encouraging consumers to prefer low-calorie, sugar-free, and ready-to-eat products, owing to their nutritional value and convenience. Manufacturers are increasingly utilizing sweeteners in food & beverages.
Neohesperidin DC is a non-nutritive sweetener, which is used in ready-to-eat foods products, which enhances the sweetness of products. Neohesperidin DC is also used as an anti-masking agent, to mask the bitter taste in food products. The neohesperidin dihydrochalcone offers a health, stability, and cost-effective solution for ready-to-eat food and drinks, and juices, which are largely preferred by consumers owing to its benefits.
The working population largely consumes these ready-to-eat products and sugar-free drinks, owing to their convenience and nutritional value. The increasing benefits of flavonoids such as Neohesperidin DC, increase its usage among consumers in the food industry, which is anticipated to create lucrative opportunities in the market.
Scope of Naringenin, Neohesperidin DC, and Phloretin Market Report
The report on the global Naringenin, Neohesperidin DC, and Phloretin Market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Naringenin, Neohesperidin DC, and Phloretin Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016-2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Type (Naringenin, Neohesperidin DC, and Phloretin), and Application (Food & Feed Additives, Pharmaceutical, Healthcare, Cosmetics, Personal Care, Chemicals, and Others) |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered |
American Elements, BioCrick BioTech, BORDAS S.A., ChemFaces, Chemodex Ltd., FINETECH INDUSTRY LIMITED, Otto Chemie Pvt. Ltd., Spectrum Chemical, Merck KGaA, Tokyo Chemical Industry Co., Ltd., Toronto Research Chemicals, Cayman Chemical, and Biosynth Carbosynth |
Naringenin, Neohesperidin DC, and Phloretin Market Segmental Outlook
Based on type, the global Naringenin, Neohesperidin DC, and Phloretin market is segmented into naringenin, Neohesperidin DC, and phloretin. The naringenin segment is expected to hold a major market share in the coming years owing to the benefits of Naringenin for the treatment of obesity, diabetes, hypertension, and metabolic syndrome.
The regular intake of Naringenin supplements helps to prevent hypercholesterolemia and lower LDL oxidation which can increase the use of Naringenin for health benefits. The Neohesperidin DC segment is projected to expand at a significant CAGR during the forecast period. Neohesperidin DC is recognized as a multitasking, economical, and stable solution in many sectors. It is widely used as a sweetener and taste enhancer in desserts, ice creams, and beverages.
In terms of the end-user industry, the market is segmented into Food & Feed Additives, Pharma & Healthcare, Cosmetics and Personal Care, Chemicals, and Others. The food & feed additives segment is estimated to hold a major share of the global market. Naringenin and Neohesperidin DC are widely used as food sweeteners and taste enhancers in the food and beverages industry, especially in desserts and ice creams.
The pharma & healthcare segment is projected to expand at a significant CAGR during the forecast period. Neohesperidin DC plays a vital role in animal feed and health industries owing to its health benefits. The daily consumption of Neohesperidin DC extracts aids to reduce cholesterol levels and prevent several other diseases which result in an increase in the use of Neohesperidin in the pharma & healthcare industry in the coming years.
On the basis of region, the global naringenin, Neohesperidin DC, and phloretin market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is projected to expand at a significant CAGR during the forecast period due to increasing demand for packaged food and an inclination toward alcoholic and non-alcoholic drinks.
The presence of huge food and beverages industry with a variety of beverages present creates new opportunities for the use of Neohesperidin DC in the regional market. Moreover, the well-established healthcare and pharma sector can increase the use of Naringenin for health benefits which can further drive the market in the region.
The market in Europe is expected to grow at a rapid pace during the forecast period owing to the rapid expansion of the food & beverage industry in the region. The rapid growth in the food & beverages and pharmaceuticals industry can boost the use of Neohesperidin DC, Phloretin, and Naringenin for various applications across different industries.
Key Benefits for Industry Participants & Stakeholders
- In-depth Analysis of the Global Naringenin, Neohesperidin DC, and Phloretin Market
- Historic, Current, and Projected Market Size in terms of Value.
- Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
- Industry Drivers, Restraints, and Opportunities Covered in the Study
- Recent Industry Trends and Developments
- Competitive Landscape & Strategies of Key Players
- Neutral Perspective on Global Naringenin, Neohesperidin DC, and Phloretin Market Performance
Segments
Type
- Naringenin
- Neohesperidin DC
- Phloretin
End-user Industry
- Food & Feed Additives
- Pharma & Healthcare
- Cosmetics & Personal Care
- Chemical
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America,
- Middle East & Africa
Key Players
- American Elements
- BORDAS S.A.
- BioCrick BioTech.
- ChemFaces
- Chemodex Ltd.
- FINETECH INDUSTRY LIMITED
- Otto Chemie Pvt. Ltd.
- Spectrum Chemical
- Merck KGaA
- Tokyo Chemical Industry Co., Ltd.
- Toronto Research Chemicals
- Cayman Chemical
Competitive Landscape
- Top players in the market include PPG Industries, Inc, Stahl Holdings B.V., among Others.
- The players are adopting key strategies such as acquisition, collaborations, and geographical expansion where potential opportunity for the global Naringenin, Neohesperidin DC, and Phloretin market.
Frequently Asked Questions
Key players competing the global market are American Elements, BioCrick BioTech, BORDAS S.A., ChemFaces, Chemodex Ltd., FINETECH INDUSTRY LIMITED, Otto Chemie Pvt. Ltd., Spectrum Chemical, Merck KGaA, Tokyo Chemical Industry Co., Ltd., Toronto Research Chemicals, Cayman Chemical, and Biosynth Carbosynth.
North America is likely to dominate the Naringenin, Neohesperidin DC, and Phloretin market during the forecast period.
Growing application of dietary bioactive or polyphenolic compounds in the food & beverage sector and rising utilization of sweeteners in food additives are some factors expected to drive market growth during the forecast period.
The global Naringenin, Neohesperidin DC, and Phloretin Market size was valued at USD 154 Mn in 2022 and is projected to reach USD 230.9 Mn by 2031, expanding at a CAGR of 4.6 % during the forecast period 2023-2031.
Table Of Content
Chapter 1 Executive SummaryChapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Naringenin, Neohesperidin DC, and Phloretin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Naringenin, Neohesperidin DC, and Phloretin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Naringenin, Neohesperidin DC, and Phloretin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Naringenin, Neohesperidin DC, and Phloretin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Naringenin, Neohesperidin DC, and Phloretin Market Size & Forecast, 2015-2030
4.5.1 Naringenin, Neohesperidin DC, and Phloretin Market Size and Y-o-Y Growth
4.5.2 Naringenin, Neohesperidin DC, and Phloretin Market Absolute $ Opportunity
4.6 Global Naringenin, Neohesperidin DC, and Phloretin Market: Pricing Analysis
4.7 Global Naringenin, Neohesperidin DC, and Phloretin Market: Impact of Key Regulations
4.8 Global Naringenin, Neohesperidin DC, and Phloretin Market: Production Process Overview
4.9 Global Naringenin, Neohesperidin DC, and Phloretin Market: Recent Industry Trends and Developments
4.10 Global Naringenin, Neohesperidin DC, and Phloretin Market: Strategies of Key Players and Product Offered
Chapter 5 Global Naringenin, Neohesperidin DC, and Phloretin Market Analysis and Forecast By Types
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities By Types
5.1.2 Basis Point Share (BPS) Analysis By Types
5.1.3 Absolute $ Opportunity Assessment By Types
5.2 Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast By Types
5.2.1 Naringenin
5.2.2 Neohesperidin DC
5.2.3 Phloretin
5.3 Market Attractiveness Analysis By Types
Chapter 6 Global Naringenin, Neohesperidin DC, and Phloretin Market Analysis and Forecast By End-user Industry
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities By End-user Industry
6.1.2 Basis Point Share (BPS) Analysis By End-user Industry
6.1.3 Absolute $ Opportunity Assessment By End-user Industry
6.2 Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast By End-user Industry
6.2.1 Food & Feed Additives
6.2.2 Pharma & Healthcare
6.2.3 Cosmetics and Personal Care
6.2.4 Chemical
6.2.5 Others.
6.3 Market Attractiveness Analysis By End-user Industry
Chapter 7 Global Naringenin, Neohesperidin DC, and Phloretin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Naringenin, Neohesperidin DC, and Phloretin Analysis and Forecast
9.1 Introduction
9.2 North America Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast By Types
9.6.1 Naringenin
9.6.2 Neohesperidin DC
9.6.3 Phloretin
9.7 Basis Point Share (BPS) Analysis By Types
9.8 Absolute $ Opportunity Assessment By Types
9.9 Market Attractiveness Analysis By Types
9.10 North America Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast By End-user Industry
9.10.1 Food & Feed Additives
9.10.2 Pharma & Healthcare
9.10.3 Cosmetics and Personal Care
9.10.4 Chemical
9.10.5 Others.
9.11 Basis Point Share (BPS) Analysis By End-user Industry
9.12 Absolute $ Opportunity Assessment By End-user Industry
9.13 Market Attractiveness Analysis By End-user Industry
Chapter 10 Europe Naringenin, Neohesperidin DC, and Phloretin Analysis and Forecast
10.1 Introduction
10.2 Europe Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast By Types
10.6.1 Naringenin
10.6.2 Neohesperidin DC
10.6.3 Phloretin
10.7 Basis Point Share (BPS) Analysis By Types
10.8 Absolute $ Opportunity Assessment By Types
10.9 Market Attractiveness Analysis By Types
10.10 Europe Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast By End-user Industry
10.10.1 Food & Feed Additives
10.10.2 Pharma & Healthcare
10.10.3 Cosmetics and Personal Care
10.10.4 Chemical
10.10.5 Others.
10.11 Basis Point Share (BPS) Analysis By End-user Industry
10.12 Absolute $ Opportunity Assessment By End-user Industry
10.13 Market Attractiveness Analysis By End-user Industry
Chapter 11 Asia Pacific Naringenin, Neohesperidin DC, and Phloretin Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast By Types
11.6.1 Naringenin
11.6.2 Neohesperidin DC
11.6.3 Phloretin
11.7 Basis Point Share (BPS) Analysis By Types
11.8 Absolute $ Opportunity Assessment By Types
11.9 Market Attractiveness Analysis By Types
11.10 Asia Pacific Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast By End-user Industry
11.10.1 Food & Feed Additives
11.10.2 Pharma & Healthcare
11.10.3 Cosmetics and Personal Care
11.10.4 Chemical
11.10.5 Others.
11.11 Basis Point Share (BPS) Analysis By End-user Industry
11.12 Absolute $ Opportunity Assessment By End-user Industry
11.13 Market Attractiveness Analysis By End-user Industry
Chapter 12 Latin America Naringenin, Neohesperidin DC, and Phloretin Analysis and Forecast
12.1 Introduction
12.2 Latin America Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast By Types
12.6.1 Naringenin
12.6.2 Neohesperidin DC
12.6.3 Phloretin
12.7 Basis Point Share (BPS) Analysis By Types
12.8 Absolute $ Opportunity Assessment By Types
12.9 Market Attractiveness Analysis By Types
12.10 Latin America Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast By End-user Industry
12.10.1 Food & Feed Additives
12.10.2 Pharma & Healthcare
12.10.3 Cosmetics and Personal Care
12.10.4 Chemical
12.10.5 Others.
12.11 Basis Point Share (BPS) Analysis By End-user Industry
12.12 Absolute $ Opportunity Assessment By End-user Industry
12.13 Market Attractiveness Analysis By End-user Industry
Chapter 13 Middle East & Africa (MEA) Naringenin, Neohesperidin DC, and Phloretin Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast By Types
13.6.1 Naringenin
13.6.2 Neohesperidin DC
13.6.3 Phloretin
13.7 Basis Point Share (BPS) Analysis By Types
13.8 Absolute $ Opportunity Assessment By Types
13.9 Market Attractiveness Analysis By Types
13.10 Middle East & Africa (MEA) Naringenin, Neohesperidin DC, and Phloretin Market Size Forecast By End-user Industry
13.10.1 Food & Feed Additives
13.10.2 Pharma & Healthcare
13.10.3 Cosmetics and Personal Care
13.10.4 Chemical
13.10.5 Others.
13.11 Basis Point Share (BPS) Analysis By End-user Industry
13.12 Absolute $ Opportunity Assessment By End-user Industry
13.13 Market Attractiveness Analysis By End-user Industry
Chapter 14 Competition Landscape
14.1 Naringenin, Neohesperidin DC, and Phloretin Market: Competitive Dashboard
14.2 Global Naringenin, Neohesperidin DC, and Phloretin Market: Market Share Analysis, 2021
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 American Elements
14.3.2 BioCrick BioTech.
14.3.3 BORDAS S.A.
14.3.4 ChemFaces
14.3.5 Chemodex Ltd.
14.3.6 FINETECH INDUSTRY LIMITED
14.3.7 Otto Chemie Pvt. Ltd.
14.3.8 Spectrum Chemical
14.3.9 Merck KGaA
14.3.10 Tokyo Chemical Industry Co., Ltd.
14.3.11 Toronto Research Chemicals
14.3.12 Cayman Chemical
14.3.13 Biosynth Carbosynth
Methodology
Related Reports
Some other reports from this category!
Our Clients
